Haleon PLC Sponsored ADR (NYSE:HLN) Receives $12.33 Consensus PT from Analysts

Key Points

• Haleon PLC Sponsored ADR has received an average analyst rating of "Moderate Buy," with a target price of $12.32 over the next year.
• Recent upgrades from analysts include a "strong-buy" rating from BNP Paribas and a "buy" rating from Goldman Sachs.
• The company announced an increase in its semi-annual dividend to $0.0555 per share, marking a yield of 190.0%.

Haleon PLC Sponsored ADR (NYSE:HLN - Get Free Report) has received an average recommendation of "Moderate Buy" from the ten analysts that are covering the stock, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation, three have assigned a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $12.3250.

HLN has been the topic of several analyst reports. BNP Paribas Exane raised Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 target price on the stock in a research report on Tuesday, May 27th. The Goldman Sachs Group raised Haleon from a "neutral" rating to a "buy" rating in a research report on Wednesday, September 10th. Barclays lowered Haleon from an "overweight" rating to an "equal weight" rating in a report on Tuesday, September 16th. BNP Paribas upgraded Haleon to a "strong-buy" rating in a research note on Tuesday, May 27th. Finally, Wall Street Zen downgraded Haleon from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th.

Hedge Funds Weigh In On Haleon

A number of hedge funds have recently bought and sold shares of HLN. Brighton Jones LLC purchased a new position in shares of Haleon in the fourth quarter valued at approximately $187,000. Ameriprise Financial Inc. increased its stake in Haleon by 15.8% during the fourth quarter. Ameriprise Financial Inc. now owns 120,122 shares of the company's stock worth $1,146,000 after acquiring an additional 16,429 shares during the last quarter. Millennium Management LLC lifted its holdings in Haleon by 82.5% during the 4th quarter. Millennium Management LLC now owns 528,891 shares of the company's stock worth $5,046,000 after buying an additional 239,019 shares during the last quarter. Royal Bank of Canada lifted its holdings in Haleon by 62.6% during the 4th quarter. Royal Bank of Canada now owns 2,733,615 shares of the company's stock worth $26,078,000 after buying an additional 1,052,462 shares during the last quarter. Finally, Two Sigma Advisers LP purchased a new stake in Haleon during the 4th quarter worth about $2,391,000. Hedge funds and other institutional investors own 6.67% of the company's stock.

Haleon Price Performance

NYSE:HLN traded down $0.08 during trading hours on Thursday, reaching $9.16. The stock had a trading volume of 9,669,121 shares, compared to its average volume of 8,421,567. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.63 and a current ratio of 0.87. Haleon has a 52 week low of $8.86 and a 52 week high of $11.42. The company has a 50 day moving average price of $9.66 and a two-hundred day moving average price of $10.16. The stock has a market capitalization of $40.99 billion, a PE ratio of 23.49, a PEG ratio of 2.71 and a beta of 0.23.

Haleon Increases Dividend

The firm also recently declared a semi-annual dividend, which was paid on Thursday, September 18th. Shareholders of record on Friday, August 15th were given a dividend of $0.0555 per share. This is an increase from Haleon's previous semi-annual dividend of $0.05. This represents a yield of 190.0%. The ex-dividend date was Friday, August 15th. Haleon's dividend payout ratio (DPR) is currently 28.21%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.